ERBB2 and neoplasm: Many known predictors for response to NAC and post-neoadjuvant prognosis relate to tumor characteristics like estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status [2], tumor grade [10]) and TNM stage [11].